Literature DB >> 19178964

C-reactive protein and left atrial appendage velocity are independent determinants of the risk of thrombogenesis in patients with atrial fibrillation.

Cinzia Cianfrocca1, Maria Luisa Loricchio, Francesco Pelliccia, Vincenzo Pasceri, Antonio Auriti, Leopoldo Bianconi, Vincenzo Guido, Giuseppe Rosano, Giuseppe Mercuro, Massimo Santini.   

Abstract

BACKGROUND: The association between inflammatory status and thrombosis in patients with atrial fibrillation (AF) is unclear. We studied the correlation between inflammation and the risk of thrombogenesis in patients with AF and the relationship of inflammation with other factors associated with thrombotic risk.
METHODS: We studied 150 consecutive patients (69 men, age 65+/-12 years) with persistent non-valvular AF who had transesophageal echocardiography prior to cardioversion. Patients underwent also measurements of high-sensitivity C-reactive protein, fibrinogen, D-dimer, and hematocrit levels.
RESULTS: Patients were divided into two groups according to the presence (n=52) or absence (n=98) of dense spontaneous echo contrast (SEC) in left atrium or left atrial appendage. The two groups were similar for age, sex, and major clinical risk factors. Patients with dense SEC had significantly larger left atrium diameter (p=0.007), lower left atrial appendage mean velocity (p<0.0001), and higher levels of C-reactive protein (p=0.003), D-dimer (p=0.008), and fibrinogen (p=0.006). At multivariate analysis, only left atrial appendage velocity (odds ratio: 19.11; 95% confidence interval 4.2-80.9) and C-reactive protein (odds ratio: 3.41; 95% confidence interval 1.2-9.8) were significantly associated with thrombus and/or dense SEC. However, there was no relationship between C-reactive protein levels and left atrial appendage velocity (p=0.24, r=-0.09).
CONCLUSIONS: Our results show that left atrial appendage velocity and C-reactive protein are independently associated with the risk of thromboembolism in AF. Thus, blood stasis and inflammation appear to constitute two major distinct components of thrombogenesis. Copyright 2008 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19178964     DOI: 10.1016/j.ijcard.2008.12.052

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  15 in total

1.  Growth differentiation factor 15 is associated with left atrial/left atrial appendage thrombus in patients with nonvalvular atrial fibrillation.

Authors:  Xiao Feng Hu; Rui Zhan; Shanhu Xu; Junjun Wang; Jiong Wu; Xiaoli Liu; Yaguo Li; Linhui Chen
Journal:  Clin Cardiol       Date:  2018-01-24       Impact factor: 2.882

Review 2.  Role of inflammation in atrial fibrillation pathophysiology and management.

Authors:  Masahide Harada; David R Van Wagoner; Stanley Nattel
Journal:  Circ J       Date:  2015-02-16       Impact factor: 2.993

Review 3.  Endothelial progenitor cells in cardiovascular disease and chronic inflammation: from biomarker to therapeutic agent.

Authors:  Johannes C Grisar; Francois Haddad; Fatemeh A Gomari; Joseph C Wu
Journal:  Biomark Med       Date:  2011-12       Impact factor: 2.851

4.  FDG atrial uptake is associated with an increased prevalence of stroke in patients with atrial fibrillation.

Authors:  Mathieu Sinigaglia; Besma Mahida; Eve Piekarski; Renata Chequer; Nidaa Mikail; Khadija Benali; Fabien Hyafil; Dominique Le Guludec; François Rouzet
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-01-25       Impact factor: 9.236

5.  Relevance of transthoracic left atrial appendage wall velocity measurement in addition to left atrial volume for noninvasive and quantitative assessment of left atrial thrombogenesis in patients with atrial fibrillation and normal D-dimer levels.

Authors:  Naoyasu Yoshida; Mitsunori Okamoto; Hidekazu Hirao; Kazuyoshi Suenari; Kiyomi Nanba; Mio Uchida; Ryo Yamazato; Yuichiro Watari; Yukihiro Fukuda; Hironori Ueda
Journal:  J Med Ultrason (2001)       Date:  2015-12-14       Impact factor: 1.314

6.  Stroke in Atrial Fibrillation - Long-term Follow-up of Cardiovascular Events.

Authors:  Tze-Fan Chao; Chern-En Chiang; Shih-Ann Chen
Journal:  Arrhythm Electrophysiol Rev       Date:  2013-11-29

7.  Relation of hs-CRP and BNP levels with the atrial spontaneous echo contrast and thrombi in permanent atrial fibrillation patients with different etiologies.

Authors:  Tayfun Sahin; Eser Acar; Umut Celikyurt; Teoman Kılıc; Guliz Kozdag; Aysen Agacdiken; Dilek Ural
Journal:  Med Sci Monit       Date:  2012-02

8.  Incidence of left atrial abnormalities under treatment with dabigatran, rivaroxaban, and vitamin K antagonists.

Authors:  Stefan Reers; Tolga Agdirlioglu; Michael Kellner; Matthias Borowski; Holger Thiele; Johannes Waltenberger; Michael Reppel
Journal:  Eur J Med Res       Date:  2016-10-21       Impact factor: 2.175

Review 9.  The Predictive Role of Inflammatory Biomarkers in Atrial Fibrillation as Seen through Neutrophil-Lymphocyte Ratio Mirror.

Authors:  Feliciano Chanana Paquissi
Journal:  J Biomark       Date:  2016-07-03

10.  Increased M1 Macrophages Infiltration Is Associated with Thrombogenesis in Rheumatic Mitral Stenosis Patients with Atrial Fibrillation.

Authors:  Guixin He; Wei Tan; Bingjian Wang; Jianzhou Chen; Guannan Li; Suhui Zhu; Jun Xie; Biao Xu
Journal:  PLoS One       Date:  2016-03-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.